Rivotra

Medicinal product

(Invented) name

Rivotra

Active substance (s)

Brimonidino tartratas

Strength

2 mg/ml

Pharmaceutical form

akių lašai (tirpalas)

Route (s) of administration

vartoti ant akių

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01EA05, Brimonidine

Marketing authorisation holder

Zakłady Farmaceutyczne POLPHARMA S.A., Lenkija

Date of authorisation

2019-10-01

Date of renewal

2025-01-13

Documents

4443_pakuotes lapelis_2025-01-13.docx

4443_Rivotra_perr2025-01-13.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

CZ/H/0867/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra:	1 ml
Brimonidino tartratas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102452	88553	1088553	buteliukas	5 ml N1		Receptinis	LT/1/19/4443/001	Tiekiama	2024-10-16	-	No	-	-	Download
102453	88554	1088554	buteliukas	5 ml N3		Receptinis	LT/1/19/4443/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-01-13	Perregistruotas
2019-10-01	Registruotas